Article Type
Changed
Fri, 01/18/2019 - 14:33
Display Headline
VIDEO: When to use glycopyrrolate as first-line hyperhidrosis therapy

KAUAI, HAWAII – When should glycopyrrolate be used as first-line therapy in the treatment of hyperhidrosis? And if it’s not the first treatment, what should take its place?

In a video report from the 2015 Hawaii Dermatology Seminar sponsored by Global Academy for Medical Education/Skin Disease Education Foundation, Dr. Christopher Zachary and Dr. Joshua Spanogle share their thoughts on the latest in hyperhidrosis treatment.

Dr. Zachary disclosed that he has financial relationships with Cutera and Solta. Dr. Spanogle disclosed he has relationships with Illumina and Quantified Skin. SDEF and this news organization are owned by the same parent company.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

References

Meeting/Event
Author and Disclosure Information

Publications
Topics
Legacy Keywords
hyperhidrosis, glycopyrrolate, WHITNEY MCKNIGHT
Author and Disclosure Information

Author and Disclosure Information

Meeting/Event
Meeting/Event

KAUAI, HAWAII – When should glycopyrrolate be used as first-line therapy in the treatment of hyperhidrosis? And if it’s not the first treatment, what should take its place?

In a video report from the 2015 Hawaii Dermatology Seminar sponsored by Global Academy for Medical Education/Skin Disease Education Foundation, Dr. Christopher Zachary and Dr. Joshua Spanogle share their thoughts on the latest in hyperhidrosis treatment.

Dr. Zachary disclosed that he has financial relationships with Cutera and Solta. Dr. Spanogle disclosed he has relationships with Illumina and Quantified Skin. SDEF and this news organization are owned by the same parent company.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

KAUAI, HAWAII – When should glycopyrrolate be used as first-line therapy in the treatment of hyperhidrosis? And if it’s not the first treatment, what should take its place?

In a video report from the 2015 Hawaii Dermatology Seminar sponsored by Global Academy for Medical Education/Skin Disease Education Foundation, Dr. Christopher Zachary and Dr. Joshua Spanogle share their thoughts on the latest in hyperhidrosis treatment.

Dr. Zachary disclosed that he has financial relationships with Cutera and Solta. Dr. Spanogle disclosed he has relationships with Illumina and Quantified Skin. SDEF and this news organization are owned by the same parent company.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

References

References

Publications
Publications
Topics
Article Type
Display Headline
VIDEO: When to use glycopyrrolate as first-line hyperhidrosis therapy
Display Headline
VIDEO: When to use glycopyrrolate as first-line hyperhidrosis therapy
Legacy Keywords
hyperhidrosis, glycopyrrolate, WHITNEY MCKNIGHT
Legacy Keywords
hyperhidrosis, glycopyrrolate, WHITNEY MCKNIGHT
Article Source

AT SDEF HAWAII DERMATOLOGY SEMINAR 2015

PURLs Copyright

Inside the Article